Close

Emergent BioSolutions (EBS), Integrated BioTherapeutics Enter Equine-Based Hyperimmunoglobulin Licensing Agreement

Go back to Emergent BioSolutions (EBS), Integrated BioTherapeutics Enter Equine-Based Hyperimmunoglobulin Licensing Agreement